Unigene Laboratories, Inc. is a biopharmaceutical company engaged in the research, production and delivery of small proteins, referred to as peptides that have demonstrated or may have potential medical use. It has a patented manufacturing technology for producing many peptides and patented oral and nasal delivery technologies that have been shown to deliver medically useful amounts of various peptides into the bloodstream. The Company's primary focus is the development of calcitonin and other peptide products for the treatment of osteoporosis and other indications. The Company has licensed worldwide rights to manufacturing and delivery technologies for oral parathyroid hormone, which it refers to as PTH, to GlaxoSmithKline. It has also licensed in the United States its nasal calcitonin product, which it has trademarked as Fortical, to Upsher-Smith Laboratories, Inc.